EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/17/2023
Back to search
Official data from USPTO
QUALIGEN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
07/29/2023
Trademark type
Combined
Nice classes
5
Filing date
03/08/2021
Registration date
09/20/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/20/2022
Last transaction
07/29/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/06/2022
First use in commerce
06/06/2022
Drawing code
3
Owner type
03
Owner location
Carlsbad, CA, US
Examiner
RINKER, ANTHONY MICHAEL
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of A stylized circle having two regions of shading gradients and inside the circle there are a series of dots with some of the dots having a lines originating from the dots or connecting the dots, underneath the stylized circle is the word "qualigen" in a stylized font in lowercase letters, underneath "qualigen" is the word "therapeutics" between the "q" and the "g" of "qualigen" in a stylized font in capital letters and the "i" in "qualigen" has a lighter shaded dot.
Holders and representatives
Holders
Qualigen, Inc.
Representatives
Mei Tsang Umberg Zipser LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and prevention of viral infections; Pharmaceutical preparations for the treatment and prevention of cancer
Publications
History of USPTO decisions and trademark events.
33 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/20/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/20/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/18/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/17/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/21/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/20/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
07/20/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/18/2022
IUAF
USE AMENDMENT FILED
06/22/2022
DRRR
DIVISIONAL REQUEST RECEIVED
06/22/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
06/22/2022
EISU
TEAS STATEMENT OF USE RECEIVED
06/22/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/27/2022
EX1G
SOU EXTENSION 1 GRANTED
04/25/2022
EXT1
SOU EXTENSION 1 FILED
04/25/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/25/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/26/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/31/2021
PUBO
PUBLISHED FOR OPPOSITION
08/31/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/23/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/23/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/23/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/23/2021
DOCK
ASSIGNED TO EXAMINER
07/22/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/07/2021
NWAP
NEW APPLICATION ENTERED
03/11/2021
Continuous trademark protection
Get notified about every new filing that threatens QUALIGEN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.